A different study on celiac disease found CLC/Gal‐10 expression to be related to both disease activity and tissue eosinophils population in intestinal lesions, suggesting CLC/Gal‐10 as a potential biomarker for assessing tissue damage and eosinophil participation in the pathogenesis of gluten intolerance.70 Here, CLC is linked to celiac disease.